About Vivosight
Vivosight is a Healthcare company based in Maidstone (United Kingdom) founded in 2006. Optical coherence tomography devices for dermatological diagnostics are provided. It operates in the Healthcare and Technology sectors. Vivosight has raised $8.9 million across 4 funding rounds from investors including Smith & Nephew, Octopus Ventures and Kent County Council. The company has 8 employees. Its chief executive, as recorded, is Jonathan Denis Holmes. Its focus areas include Semiconductors, Photonics, Biophotonics and Imaging. Its legal entity is MICHELSON DIAGNOSTICS LTD.
Company details
Founded in 2006 in Maidstone, United Kingdom, optical coherence tomography diagnostic devices for dermatology are provided by the company. Medical imaging technology is developed to produce detailed sub-surface images of skin. Non-invasive diagnosis and monitoring of skin conditions, including non-melanoma skin cancer, are facilitated. Lesion information beyond clinical or dermoscopic visibility is generated, supporting treatment decisions at initial appointments and during follow-ups.
- Headquarters Maidstone, United Kingdom
- Employees 8
- SectorsHealthcareTechnology
- Website vivosight.com
- Social X Facebook
- Legal Name Michelson Diagnostics Ltd
- Date of Incorporation 07 Mar, 2006
- Jurisdiction NOTTINGHAM, ENGLAND
- Total Equity Funding$8.9M (USD)
in 4 rounds
- Latest Funding Round$3.37M (USD), Series B
Feb 2015
- InvestorsSmith & Nephew
& 4 more
- Employee Count8
Funding Insights of Vivosight
Vivosight has successfully raised a total of $8.9M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $3.37 million completed in February 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8.9M
- Total Rounds 4
- Last Round Series B — $3.37M
- First Round $1.94M
(Oct 2010)
- Investors Count 5
All 4 funding rounds of Vivosight with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2015 | $3.37M | Series B | – | Smith & Nephew | |
| Jan 2014 | $3.25M | Series A | – | – | |
| Mar 2011 | $345,356 | Series A | – | – | |
| Oct 2010 | $1.94M | Series A | – | – |
5 investors in total: 5 institutional.
Investors in Vivosight
Vivosight has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Smith & Nephew, Octopus Ventures and Kent County Council.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investment and support for founders in technology and health sectors. | octopusventures.com | |||
Investment solutions are provided by Catapult Ventures for growth. | catapult-ventures.com | Leicester, United Kingdom | ||
Manufacturer of knee, hip and shoulder joint replacements | 1856 | smith-nephew.com | London, United Kingdom | |
| kent.gov.uk | ||||
Delivers comprehensive investment services for businesses. | 1982 | lbangels.co.uk | London, United Kingdom |
Investor details for Vivosight
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Vivosight
4 people are tracked at Vivosight (3 in leadership, 1 in team); the tracked headcount is 8.
| Name | Role | Group |
|---|---|---|
Jonathan Denis Holmes | CEO | Leadership |
Craig Fortier | Director Of Business Development | Leadership |
Jon Holmes | CEO | Leadership |
Therese P Perrin | Financial Services Consultant | Team |
Complete people profiles for Vivosight
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Vivosight
3 dated milestones of Vivosight across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Vivosight is founded.
- Funding First funding round of $1.9M.
- Funding Latest funding round, Series B, of $3.4M.
Web traffic of Vivosight
The website of Vivosight (vivosight.com) receives about 2.8K visits a month.
- Monthly visits2.8K
▲ 47% vs previous month
Top companies in Imaging Diagnostics
2 companies that operate in the same segment as Vivosight (Imaging Diagnostics) in United Kingdom, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Technology tools and systems for molecular scale are developed. | 1959 | Abingdon, Oxfordshire, United Kingdom | USD 648.1 M | |||
Planar X-ray radiology products for diagnostic imaging are supplied. | 2000 | Oxford, Oxfordshire, United Kingdom | USD 43.43 M | USD 1.04 M | 50 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Vivosight
Complete news archive for Vivosight
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vivosight
Vivosight was founded in 2006 and raised its 1st funding round 4 years after it was founded.
Vivosight is headquartered in Maidstone, United Kingdom.
Jonathan Denis Holmes is the CEO of Vivosight, as recorded in our data.
Vivosight is a funded company, having raised a total of $8.9M across 4 funding rounds to date. The company's 1st funding round was a Series A of $1.94M, raised on Oct 2010.
Vivosight has 8 employees.
Founded in 2006 in Maidstone, United Kingdom, optical coherence tomography diagnostic devices for dermatology are provided by the company. Medical imaging technology is developed to produce detailed sub-surface images of skin. Non-invasive diagnosis and monitoring of skin conditions, including non-melanoma skin cancer, are facilitated. Lesion information beyond clinical or dermoscopic visibility is generated, supporting treatment decisions at initial appointments and during follow-ups.
Vivosight has 5 investors. Key investors include Smith & Nephew, Octopus Ventures, Kent County Council, London Business Angels, and Catapult Ventures.
Vivosight operates through Michelson Diagnostics Ltd.